% | $
Quotes you view appear here for quick access.


  • djk69_yum djk69_yum Sep 14, 1998 12:52 PM Flag

    Schein's Steris Labs and Delatestryl(R)

    My information may be a little dated but I
    believe BioTech's Delatestryl (testosterone enanthate)
    competes with a strong selling testosterone enanthate made
    by Steris. For those who have not heard, the FDA is
    seizing products made by Steris. I'm thinking that maybe
    BTGC's Delatestryl could fill the testosterone void
    created by this Steris snafu. Test Enanthate is a fairly
    low priced product so I would imagine that
    Delatestryl is a low margin product but I'll take whatever
    this opportunity, either top or bottom line, may
    deliver. I plan to do a little more digging on this, but
    if anybody beats me to it, please post. Thanks,

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The scenario I painted in BTGC post #1641 may
      indeed yield some increase to BTG�s top line revenue
      growth that is not yet in the analyst�s projections.
      (Please reread my post #1641)

      I may have a
      follow up to the scenario I posed but I would like to
      first ask a quick question relating to the use of
      Internet boards. Can I legally cut and paste other
      people�s messages from a �discussion type� of message
      board? Do I need to remove the names and e-mail
      addresses? Please caution me if needed. Thanks, David

      • 1 Reply to djk69_yum
      • I believe the only exposure from cutting posts
        from one board to post on another would be if the
        poster claimed the text as an original work and placed
        the appropriate symbol and notices. Since these
        boards are "public domain" -type environments, even if a
        poster claimed copyright for an original post the
        absence of a commercial motive (did you get paid for the
        reposted text?) would make it very hard to collect The
        reason I use the term "original post" is that to
        knowingly repost copyrighted material might get you sued by
        the copyright holder just to make you spend the money
        defending yourself (and to stop others from doing it in the
        future, of course). At the end of the day, such recourse
        is rare & would really have to be blatant before an
        entity would go to the expense of lawsuit and discovery
        just to get to you.

        If someone gave their
        "handle" or email addr in an open forum, I'd pass it on in
        the repost so that credit for the original
        thought/work is passed on too.

        AKA Amazed_ ...

    • Need to read BTGC post #1641 for background
      purposes and to put the next couple of my posts into
      The following was copied and pasted from an e-medical
      support group thread............


      I am on testosterone replacement injections. I have
      been told that the major producer of testosterone
      enanthate and cypionate is out of business and they will be
      unavailable in a few weeks. Is this just a bad rumor or does
      anone know if it is

      I am also on bi-weekly testosterone injections. I
      have heard nothing about it becomig unavailable. My
      next shot will be on Monday and I'll ask my urologist
      if there is any truth to the rumor you heard. I hope
      not because I'm already reaping the benefits of this

      • 1 Reply to djk69_yum
      • John J.
        I now have confirmation
        of this.
        A couple of months ago my pharmacy told
        me they were unable to refill my prescription, as
        their suppliers were out of stock. At that time, the
        pharmacist told me the rumor mill had it that the feds were
        cracking down on the manufacturers because the stuff was
        getting into illegal channels. (Testosterone is popular
        among weightlifters.)
        I called my doc and he hadn't
        heard any such problems. To get me by he simply sold me
        a bottle from his supply.
        That was a couple
        months ago. I stopped at the pharmacy several times
        since then, always inquiring if they were able to get
        it. The pharmacist always checked in the computer for
        me, but they still could not get it. This is an old
        pharmacy that has been in business for 100+ years --
        second generation pharmacist. The pharmacist told me he
        was able to manufacture it himself, but wouldn't fill
        my prescription that way without an OK from my doc.
        Since my doc had supplied me himself, there was no need
        for him to give the pharmacist the OK.
        The other
        day I used the last shot in the bottle my doc sold
        me. First I called the pharmacy to see if there was
        any last-minute news. The pharmacist said he was
        still unable to get it. Then he told me that the
        manufacturer of the bottle my doc had sold me (I had shown it
        to th pharmacist earlier) had just been closed down
        by the feds. Then I dropped in to see my doc to get
        another bottle. This time the story was different. My doc
        was now able to confirm the problem. Evidently the
        pharmacist was slightly incorrect. One manufacturer (Steris,
        one of the largest) was, indeed, closed down by the
        feds. Not for letting the stuff get into illegal
        channels, but because of impurities, and failing to keep
        accurate records of sales so they could do a proper
        recall. In addition, my doc said there was
        large facility that blew down in a hurricane or
        something. He didn't say what manufacturer that was.
        we have two large production facilities suddenly out
        of the
        picture. The price in the marketplace has
        doubled because of the
        shortage. My doc sold me one
        bottle from his limited supply, and gave me a scrip for
        two bottles and wished me luck seeing if I could get
        it filled. I promised to keep him informed if I find
        a pharmacy in town with any left.
        I also
        mentioned to my doc that my regular pharmacist is willing
        to manufacture it. The doc said he also knew of a
        couple other
        pharmacists who are manufacturing it,
        but we want to try to find a regular source if we
        can. If we can't, we'll just go to the pharmacy and
        let them make it for us. According to my doc, the
        only problem with having the pharmacy make it is that
        he is worried about impurities.
        But hey, Steris
        was evidently shipping the stuff with
        anyway <shrug>.
        So that's the story, gents. Get
        it if you can. It may be a while
        before the
        supply normalizes again.

    • Copyright � 1998 - AIDS Treatment News. AIDS
      Treatment News, Subscription and Editorial Office, P.O. Box
      411256, San Francisco, CA 94141, TEL: 800/TREAT-1-2;
      415/255-0588; FAX: 415/255-4659

      <There is a nationwide shortage of
      certain injectable testosterone products. At this time we
      do not know how serious the problem is.
      Generic testosterone cypionate has been unavailable for
      weeks in San Francisco, and presumably throughout the
      U.S. (although some stocks may still remain). No one
      is currently manufacturing generic testosterone
      cypionate or enanthate for the U.S. market, and there are
      no immediate plans to resume production.

      Testosterone enanthate, according to two leading HIV
      physicians we contacted, is basically equivalent to
      testosterone cypionate and can be substituted for most
      patients (rarely someone may be allergic to one but not
      the other). Generic testosterone enanthate is
      currently in stock in many pharmacies, but shortages are
      expected. One San Francisco physician has had no problems
      prescribing it, with patients filling their prescriptions at
      pharmacies. But another physician, whose managed-care
      contract requires that he inject the drug in his office,
      has been unable to obtain supplies even after calling
      distributors around the country; he has also had problems
      obtaining nandrolone decanoate, an anabolic steroid.>
      Cont. next post

      • 1 Reply to djk69_yum
      • <* If the generic drugs are unavailable,
        physicians can use brand-name versions, which cost several
        times as much--or switch to other expensive options
        such as one of the testosterone patches, (Androderm�
        or Testoderm�) or the oral anabolic oxandrolone
        (Oxandrin�). At least one non-generic testosterone
        product--Depo-Testosterone� 200mg/10mL--has been back-ordered since September
        28. A brand of testosterone
        enanthate--Delatestryl�--is available, with no supply problems expected. The
        same is also true for the testosterone patches whose
        manufacturers have told AIDS TREATMENT NEWS that ample supply
        is available.

        * The additional expense is
        especially problematic for HIV physicians under certain
        managed-care contracts. Even in San Francisco, some leading
        HIV specialists have been forced into contracts with
        no AIDS "carve out"--which means they are paid about
        $5 per month to cover office visits for a person
        with AIDS, the same as for a healthy middle-aged
        adult. The additional reimbursement for a testosterone
        injection barely covers the cost of the medicine for the
        cheapest generics. Many physicians who specialize in AIDS
        care are losing money on every patient and being
        forced to pay for their AIDS practice by taking on other
        work; they have no margin to cover the sharply
        increased cost of non-generic testosterone.

        How the
        Shortage Happened

        On September 10, 1998 the FDA
        moved against Steris Laboratories, Inc. (a division of
        Schein Pharmaceutical, Inc.), seizing large stocks of
        their drugs and ordering a halt in further production
        of all products at that facility; Steris, located in
        Phoenix, Arizona, laid off about 350 workers. The FDA has
        not said that any of the drugs are bad, but that the
        company had not followed required procedures for
        documenting quality assurance.

        Steris had been
        manufacturing all the generic testosterone cypionate and
        enanthate sold in the U.S., even that which is sold by
        other companies.> Cont. next post

    • buying this company?

    • Zoltar:
      Glad to see you are still around,
      I'll try to relay that information like you

      Zolt's last sentenced summed it up best "...the
      company is getting increased sales from an unexpected

      The results of this will not be a grand slam or even
      a homerun. But this is a company hitting singles
      and doubles that the Street, eventually, will come to
      appreciate. I�ll post if I find out more.

    • 1,656 posts ago I picked up on the future
      increase in Delatestryl sales mentioned by Sim in the
      conference call. (I don't remember one analyst's report
      breathing a word about it back then)

      I'll go on
      record once more. Anybody already writing off Oxandrin
      as finished (in the HIV wasting arena), please
      revisit this message about another 1,600 posts from now
      to see how wrong you are.

      PS I still plan on
      selling a kidney to buy more shares of BTGC if it ever
      breaks 4 bucks. (and I'm hoping it does)

    • (BTGC) Quarterly Report (SEC form 10-Q) Aug 1999
      (Qtrly Rpt)

      Comparison of Three Months Ended June
      30, 1999 and June 30, 1998
      Revenues: Product
      sales of � Delatestryl increased $2,102,000 or 877%.
      compared to the same period in 1998

      of Six Months Ended June 30, 1999 and June 30, 1998

      Revenues: Product sales of�Delatestryl increased $3,457,000
      or 810% compared to the first half of

      Show me one analyst who picked up on this before I
      did. It's called knowing your company, the market they
      serve, their competitors, and the relative demand for
      the products they sell. It's not Merrill Lynch
      telling you to buy it, or what some brokerage analyst is
      rating it or even what some self-proclaimed tech guru is
      saying in a recent newsletter or magazine. Nor is it
      just blindly regurgitating what the company's top
      management is saying. And it sure is not found in any kind
      of chart showing the historical movement of the
      stock. In other words, your own due diligence is

      attitudesup41: Regarding the two unreturned calls, you are
      probably better off. Let's face it folks, this IR
      department is not exactly the brightest group of people
      around. When I first called our company back in September
      about the possibility of BTG Corp exploiting the
      testosterone shortage with their Delatestryl product, it took
      about three days and a half dozen phone calls before
      Leah and company even knew what I was talking about.
      They kept coming back with some kind of answer stating
      "Andro-Tab did not pass phase three trials and we now plan
      to blah blah blah�" I finally said screw it. Compare
      this to the recently acquired Unimed Corp who makes a
      competing product. I would call them with a question or an
      idea and the CEO would return my call personally
      within a day or two.

      Lastly, does anybody ever
      wonder why some of the old time holders seldom post
      anymore? It's not that they sold their shares, it's just
      that whenever someone makes a valid, critical point
      about the company, the response back is typically "duh,
      you are short�. Gooo BTGC!!!" It's just not worth it

      • 1 Reply to djk69_yum
      • < Show me one analyst who picked up on this
        before I did.>

        Don't know if they picked up on
        it. I caught this back in April in the 4/15
        conference call. They stated that delatestryl could be in
        the $8 to $12 million range this year and that they
        were on a run rate of $8.8 at the time. This was the
        main reason I held onto some of my shares, thinking
        perhaps this could make up for the expected shortfall in
        Oxandrin due to Olsten cutting back. And getting anything
        of substance out of BTGC is like pulling

        And you are SOOOO right about certain people not
        wanting to hear anything but rah-rah type posts. The
        problem with those people oftentimes is that they are
        emotionally attached to the stock.

    • Six Months Ended Three Months Ended
      June 30,
      1999 June 30, 1999
      1999 1998 1999 1998
      ----- ----- ------
      Oxandrin...... 38.5% 60.7% 35.3%
      Bio-Tropin.... 37.7 27.0 42.6 26.6
      BioLon........ 11.5 9.3
      9.1 9.2
      Delatestryl... 11.0 1.3 12.0
      Other......... 1.3 1.7 1.0 0.8
      ------ ------ ------
      Total......... 100.0% 100.0% 100.0% 100.0%
      ====== ======